Similar articles

• The modern crystal ball: influenza forecasting with mathematical models.

  Kansagra SM, Farley TA. Kansagra SM, et al. Ann Intern Med. 2009 Dec 15;151(12):886-7. doi: 10.7326/0003-4819-151-12-200912150-00154. Ann Intern Med. 2009. PMID: 20008763 No abstract available.
• Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemic.

  Khazeni N, Hutton DW, Garber AM, Owens DK. Khazeni N, et al. Ann Intern Med. 2009 Dec 15;151(12):840-53. doi: 10.7326/0003-4819-151-12-200912150-00156. Ann Intern Med. 2009. PMID: 20008760 Free PMC article.
• Effectiveness and cost-effectiveness of vaccination against pandemic influenza (H1N1) 2009.

  Khazeni N, Hutton DW, Garber AM, Hupert N, Owens DK. Khazeni N, et al. Ann Intern Med. 2009 Dec 15;151(12):829-39. doi: 10.7326/0003-4819-151-12-200912150-00157. Ann Intern Med. 2009. PMID: 20008759 Free PMC article.
• Influenza vaccines: the good, the bad, and the eggs.

  Schultz-Cherry S, Jones JC. Schultz-Cherry S, et al. Adv Virus Res. 2010;77:63-84. doi: 10.1016/B978-0-12-385034-8.00003-X. Adv Virus Res. 2010. PMID: 20951870 Review.
• DNA-based influenza vaccines: evaluating their potential to provide universal protection.

  Choo AY, Broderick KE, Kim JJ, Sardesai NY. Choo AY, et al. IDrugs. 2010 Oct;13(10):707-12. IDrugs. 2010. PMID: 20878593 Review.